Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.
Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.
Market Analysis and Insights: Global Companion Diagnostic Technologies Market
In 2019, the global Companion Diagnostic Technologies market size was US$ 2544.9 million and it is expected to reach US$ 5442.7 million by the end of 2026, with a CAGR of 11.3% during 2021-2026.
Global Companion Diagnostic Technologies Scope and Market Size
Companion Diagnostic Technologies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Companion Diagnostic Technologies market is segmented into Immunohistochemistry, Molecular Diagnostics, etc.
Segment by Application, the Companion Diagnostic Technologies market is segmented into Oncology, Cardiovascular, Central Nervous System, Auto immune & Inflammation, Virology, Others, etc.
Regional and Country-level Analysis
The Companion Diagnostic Technologies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Companion Diagnostic Technologies market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Companion Diagnostic Technologies market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Companion Diagnostic Technologies business, the date to enter into the Companion Diagnostic Technologies market, Companion Diagnostic Technologies product introduction, recent developments, etc.
The major vendors include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd., Leica Microsystems, Danaher, etc.
This report focuses on the global Companion Diagnostic Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher
Immunohistochemistry
Molecular Diagnostics
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Companion Diagnostic Technologies status, future forecast, growth opportunity, key market and key players.
To present the Companion Diagnostic Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Companion Diagnostic Technologies are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.
Market Analysis and Insights: Global Companion Diagnostic Technologies Market
In 2019, the global Companion Diagnostic Technologies market size was US$ 2544.9 million and it is expected to reach US$ 5442.7 million by the end of 2026, with a CAGR of 11.3% during 2021-2026.
Global Companion Diagnostic Technologies Scope and Market Size
Companion Diagnostic Technologies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Companion Diagnostic Technologies market is segmented into Immunohistochemistry, Molecular Diagnostics, etc.
Segment by Application, the Companion Diagnostic Technologies market is segmented into Oncology, Cardiovascular, Central Nervous System, Auto immune & Inflammation, Virology, Others, etc.
Regional and Country-level Analysis
The Companion Diagnostic Technologies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Companion Diagnostic Technologies market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Companion Diagnostic Technologies Market Share AnalysisCompanion Diagnostic Technologies market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Companion Diagnostic Technologies business, the date to enter into the Companion Diagnostic Technologies market, Companion Diagnostic Technologies product introduction, recent developments, etc.
The major vendors include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd., Leica Microsystems, Danaher, etc.
This report focuses on the global Companion Diagnostic Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher
Market segment by Type, the product can be split into
Immunohistochemistry
Molecular Diagnostics
Market segment by Application, split into
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Companion Diagnostic Technologies status, future forecast, growth opportunity, key market and key players.
To present the Companion Diagnostic Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Companion Diagnostic Technologies are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
